Oaktree Specialty [OCSL] vs BlackRock Science [BSTZ] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Oaktree Specialty Lending Corporation wins in 5 metrics, BlackRock Science and Technology Trust II wins in 7 metrics, with 2 ties. BlackRock Science and Technology Trust II appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Oaktree Specialty Lending Corporation | BlackRock Science and Technology Trust II | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.69 | 5.48 | BlackRock Science and Technology Trust II |
| Price-to-Book Ratio | 0.77 | N/A | N/A |
| Debt-to-Equity Ratio | 112.40 | 0.00 | Tie |
| PEG Ratio | -1.04 | N/A | N/A |
| Profit Margin (TTM) | 10.58% | 0.00% | Oaktree Specialty Lending Corporation |
| Operating Margin (TTM) | 84.38% | 0.00% | Oaktree Specialty Lending Corporation |
| EBITDA Margin (TTM) | 84.38% | N/A | N/A |
| Return on Equity | 2.24% | 18.31% | BlackRock Science and Technology Trust II |
| Return on Assets (TTM) | 5.20% | 17.93% | BlackRock Science and Technology Trust II |
| Free Cash Flow (TTM) | $228.37M | $877.82M | BlackRock Science and Technology Trust II |
| Dividend Yield | 17.23% | 12.35% | Oaktree Specialty Lending Corporation |
| 1-Year Return | -18.25% | 56.86% | BlackRock Science and Technology Trust II |
| Price-to-Sales Ratio (TTM) | 3.60 | 5.61 | Oaktree Specialty Lending Corporation |
| Enterprise Value | $2.63B | $0 | Oaktree Specialty Lending Corporation |
| EV/Revenue Ratio | 8.63 | 0.00 | Tie |
| Revenue per Share (TTM) | $3 | N/A | N/A |
| Earnings per Share (Diluted) | $0.36 | $4.65 | BlackRock Science and Technology Trust II |
| Beta (Stock Volatility) | 0.56 | N/A | N/A |
| Short % of Float | 3.29% | 0.08% | BlackRock Science and Technology Trust II |
Oaktree Specialty Lending Corporation vs BlackRock Science and Technology Trust II Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Oaktree Specialty Lending Corporation | 3.47% | 3.21% | -5.27% | 5.25% | -10.01% | -3.93% |
| BlackRock Science and Technology Trust II | -0.74% | 1.22% | 13.79% | 37.32% | 36.04% | 33.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Oaktree Specialty Lending Corporation | -18.25% | -36.11% | -41.29% | -20.74% | -0.83% | -2.37% |
| BlackRock Science and Technology Trust II | 56.86% | 70.02% | -19.41% | 46.15% | 46.15% | 46.15% |
Performance & Financial Health Analysis: Oaktree Specialty Lending Corporation vs BlackRock Science and Technology Trust II
| Metric | OCSL | BSTZ |
|---|---|---|
| Market Information | ||
| Market Cap | $1.10B | $1.77B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,217,165 | 188,948 |
| 90 Day Avg. Volume | 1,110,602 | 211,439 |
| Last Close | $12.22 | $30.69 |
| 52 Week Range | $10.63 - $14.77 | $19.23 - $31.58 |
| % from 52W High | -17.26% | -2.82% |
| All-Time High | $30.60 (Jul 07, 2014) | $43.76 (Nov 08, 2021) |
| % from All-Time High | -60.07% | -29.87% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.13% | N/A |
| Quarterly Earnings Growth | -0.23% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.00% |
| Operating Margin (TTM) | 0.84% | 0.00% |
| Return on Equity (TTM) | 0.02% | 0.18% |
| Debt to Equity (MRQ) | 112.40 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.30 | N/A |
| Cash per Share (MRQ) | $0.92 | N/A |
| Operating Cash Flow (TTM) | $965,000 | $7.07M |
| Levered Free Cash Flow (TTM) | $181.58M | $314.36M |
| Dividends | ||
| Last 12-Month Dividend Yield | 17.23% | 12.35% |
| Last 12-Month Dividend | $2.09 | $2.64 |
Valuation & Enterprise Metrics Analysis: Oaktree Specialty Lending Corporation vs BlackRock Science and Technology Trust II
| Metric | OCSL (Apr 24, 2026) | BSTZ (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.69 | 5.48 |
| Forward P/E | 8.45 | N/A |
| PEG Ratio | -1.04 | N/A |
| Price to Sales (TTM) | 3.60 | 5.61 |
| Price to Book (MRQ) | 0.77 | N/A |
| Market Capitalization | ||
| Market Capitalization | $1.10B | $1.77B |
| Enterprise Value | $2.63B | $0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.63 | 0.00 |
| Enterprise to EBITDA | N/A | N/A |
| Risk & Other Metrics | ||
| Beta | 0.56 | N/A |
| Book Value per Share (MRQ) | $16.30 | N/A |
Financial Statements Comparison: Oaktree Specialty Lending Corporation vs BlackRock Science and Technology Trust II
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | OCSL (2025) | BSTZ (2025) |
|---|---|---|
| Revenue/Sales | 24.95M | 316.13M |
| Cost of Goods Sold | N/A | N/A |
| COGS % of Revenue | 0.0% | 0.0% |
| Gross Profit | N/A | N/A |
| Gross Margin | 0.0% | 0.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| Operating Margin | 0.0% | 0.0% |
| EBITDA | N/A | N/A |
| EBITDA Margin | 0.0% | 0.0% |
| Pre-Tax Income | 35.18M | 314.36M |
| Pre-Tax Income % of Revenue | 141.0% | 99.4% |
| Income Tax | 1.26M | N/A |
| Income Tax % of Revenue | 5.0% | 0.0% |
| Net Income (Profit) | 33.92M | 314.36M |
| Profit Margin | 135.9% | 99.4% |
Balance Sheet & Liquidity Metrics
| Metric | OCSL (2025) | BSTZ (2025) |
|---|---|---|
| Cash & Equivalents | 79.63M | 722,140 |
| Total Current Assets | N/A | N/A |
| Total Current Assets % of Revenue | 0.0% | 0.0% |
| Total Current Liabilities | N/A | N/A |
| Total Current Liabilities % of Revenue | 0.0% | 0.0% |
| Long-Term Debt | 1.49B | N/A |
| Long-Term Debt % of Revenue | 5,959.2% | 0.0% |
| Total Shareholders Equity | 1.47B | 1.72B |
| Retained Earnings | -885.14M | 774.43M |
| Retained Earnings % of Revenue | -3,547.5% | 245.0% |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison
| Metric | OCSL (2025) | BSTZ (2025) |
|---|---|---|
| Operating Cash Flow | 36.37M | 7.07M |
| Operating Cash Flow % of Revenue | 145.7% | 2.2% |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | 228.37M | 877.82M |
| FCF Margin | 915.3% | 277.7% |
| Debt Repayment | -965.00M | N/A |
| Common Stock Repurchase | -10.67M | -723.97M |
Short Interest & Institutional Ownership Analysis
| Metric | OCSL | BSTZ |
|---|---|---|
| Shares Short | 2.89M | 57,419 |
| Short Ratio | 3.36 | 0.39 |
| Short % of Float | 3.29% | 0.08% |
| Shares Outstanding | 88.09M | 68.74M |
| Float Shares | N/A | N/A |
| % Held by Insiders | 0.30% | 0.01% |
| % Held by Institutions | 50.28% | 30.88% |
| % Held by Public | 49.42% | 69.11% |
Dividend Analysis & Yield Comparison: Oaktree Specialty Lending Corporation vs BlackRock Science and Technology Trust II
| Metric | OCSL | BSTZ |
|---|---|---|
| Last 12-Month Dividend | $2.09 | $2.64 |
| Last 12-Month Dividend Yield | 17.23% | 12.35% |
| 3-Year Avg Annual Dividend | $2.19 | $2.19 |
| 3-Year Avg Dividend Yield | 3.08% | 0.94% |
| 3-Year Total Dividends | $6.56 | $6.56 |
| Ex-Dividend Date | Mar 16, 2026 | Mar 13, 2026 |